Pacer Advisors, Inc. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
Pacer Advisors, Inc. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$240,997
-70.9%
8,969
-61.3%
0.00%
-66.7%
Q2 2023$827,027
+282.2%
23,192
+172.2%
0.00%
+200.0%
Q1 2023$216,408
-73.7%
8,520
-58.0%
0.00%
-75.0%
Q4 2022$822,962
+116.6%
20,290
+76.5%
0.00%
+33.3%
Q3 2022$380,000
+75.9%
11,497
+144.3%
0.00%
+50.0%
Q1 2022$216,000
-78.7%
4,707
-69.3%
0.00%
-80.0%
Q4 2021$1,016,000
+12.4%
15,319
+5.8%
0.01%
-9.1%
Q3 2021$904,000
-33.4%
14,485
-11.6%
0.01%
-42.1%
Q2 2021$1,357,000
+68.8%
16,383
+35.1%
0.02%
+35.7%
Q1 2021$804,000
-20.4%
12,130
-7.8%
0.01%
-26.3%
Q4 2020$1,010,000
-15.8%
13,161
-52.7%
0.02%
-26.9%
Q3 2020$1,199,000
-44.4%
27,844
-18.1%
0.03%
-73.2%
Q4 2019$2,157,000
+267.5%
34,008
+63.3%
0.10%
+646.2%
Q3 2019$587,000
+162.1%
20,820
+77.9%
0.01%
+62.5%
Q3 2018$224,00011,7040.01%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,264$54,392,00033.22%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$216,228,00028.00%
L1 Capital Pty Ltd 296,024$19,629,0004.93%
Aquilo Capital Management, LLC 407,926$27,050,0004.89%
Evolutionary Tree Capital Management, LLC 72,948$4,837,0002.86%
ACUTA CAPITAL PARTNERS, LLC 108,000$7,161,0002.58%
First Light Asset Management, LLC 536,836$35,598,0002.36%
Parkman Healthcare Partners LLC 70,089$4,648,0001.08%
Hood River Capital Management LLC 357,082$23,678,0000.76%
Vanguard Capital Wealth Advisors 11,099$703,565,0000.60%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders